These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure. Remme WJ; van der Ent M; Bartels GL; van Schelven D; van Hoogenhuyze DC; Krauss XH; Kruijssen HA; Storm CJ Cardiovasc Drugs Ther; 1996 May; 10(2):137-44. PubMed ID: 8842505 [TBL] [Abstract][Full Text] [Related]
27. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency]. Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285 [TBL] [Abstract][Full Text] [Related]
28. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure. Amin DK; Shah PK; Hulse S; Shellock F Am Heart J; 1985 May; 109(5 Pt 1):1006-12. PubMed ID: 3158182 [TBL] [Abstract][Full Text] [Related]
29. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure. Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356 [TBL] [Abstract][Full Text] [Related]
30. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246 [TBL] [Abstract][Full Text] [Related]
31. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure. Cusick DA; Pfeifer PB; Quigg RJ Am J Cardiol; 1998 Nov; 82(9):1060-5. PubMed ID: 9817482 [TBL] [Abstract][Full Text] [Related]
32. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography. Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514 [TBL] [Abstract][Full Text] [Related]
33. Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan. Moe GW; Rouleau JL; Charbonneau L; Proulx G; Arnold JM; Hall C; de Champlain J; Barr A; Sirois P; Packer M Am Heart J; 2000 Apr; 139(4):587-95. PubMed ID: 10740139 [TBL] [Abstract][Full Text] [Related]
34. Early and medium term results of tailored therapy for heart failure. Martins S; Soares RM; do Rosário L; Quininha J; Antunes AM Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309 [TBL] [Abstract][Full Text] [Related]
35. ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada. Parker AB; Azevedo ER; Baird MG; Smith SJ; Arnold JM; Humen DP; Moe GW; Parker JO; Butt RW; Parker JD Am Heart J; 1999 Nov; 138(5 Pt 1):843-8. PubMed ID: 10539814 [TBL] [Abstract][Full Text] [Related]
36. Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure. Rauch B; Zimmermann R; Kapp M; Haass M; Von Molitor S; Smolarz A; Neumann FJ; Kübler W; Dietz R; Tillmanns H Clin Cardiol; 1991 May; 14(5):386-95. PubMed ID: 2049889 [TBL] [Abstract][Full Text] [Related]
37. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Sütsch G; Kiowski W; Yan XW; Hunziker P; Christen S; Strobel W; Kim JH; Rickenbacher P; Bertel O Circulation; 1998 Nov; 98(21):2262-8. PubMed ID: 9826312 [TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables. Pacher R; Stanek B; Hülsmann M; Bojic A; Berger R; Frey B; Siegel A; Kos T; Ogris E; Grimm M; Laufer G J Heart Lung Transplant; 1997 Aug; 16(8):878-81. PubMed ID: 9286780 [TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation. Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469 [TBL] [Abstract][Full Text] [Related]
40. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database. Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]